MS
Last updated: 01 November 2019
You can legally access new medicines, even if they are not approved in your country.
Learn more »The Scottish Medicines Consortium (SMC) has approved Mavenclad (cladribine) as a treatment for highly active relapsing multiple sclerosis.
Read more
